China · Delayed Price · Currency is CNY Sichuan Kelun Pharmaceutical Company Description
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China.
The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion set, dispensing and injection syringes, detained needles, nebulizer, and vacuum blood collection tubes; over-the-counter products; and APIs for treatment of cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications.
It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injection.
The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 21,864 |
| CEO | Sichuan Liu |
Contact Details
Address: No.36 West Baihua Road Chengdu, 610071 China | |
| Phone | 86 40 0686 0333 |
| Website | kelun.com |
Stock Details
| Ticker Symbol | 002422 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000PW7 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sichuan Liu | GM and Director |
| Degui Lai | Chief Financial Officer and Deputy GM |
| Hao Feng | Deputy GM and Secretary of the Board of Directors |
| Tan Hongbo | Deputy General Manager |
| Zhonghua Wu | Deputy General Manager |
| Yihong Liao | Deputy General Manager |
| Deguang Chen | Officer |